cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Emergent Biosolutions Inc
23 own
13 watching
Current Price
$5.55
$0.28
(5.31%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
124.32M
52-Week High
52-Week High
9.96000
52-Week Low
52-Week Low
1.42000
Average Volume
Average Volume
2.48M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
7.8326
iconMarket Capitalization124.32M
icon52-Week High9.96000
icon52-Week Low1.42000
iconAverage Volume2.48M
iconDividend Yield--
iconP/E Ratio7.8326
What does the Emergent Biosolutions Inc do?
Emergent BioSolutions Inc. focuses on the development, manufacture, and commercialization of medical countermeasures that address public health threats. Its products address public health threats primarily chemical, biological, radiological, nuclear, and explosive-related threats, as well as infectious diseases. The company's marketed products include BioThrax, an anthrax vaccine; Anthrasil, a polyclonal antibody for the treatment of inhalational anthrax; BAT (Botulism Antitoxin Heptavalent) for the treatment of botulinum disease; vaccinia immune globulin intravenous that addresses adverse events from smallpox vaccination; reactive skin decontamination lotion kit for the removal or neutralization of chemical warfare agents; and Trobigard, an auto-injector device designed for intramuscular self-injection of atropine sulfate and obidoxime chloride. Its investigational stage product candidates include NuThrax, a next generation anthrax vaccine; UV-4B for dengue and influenza infections; GC-072 for Burkholderia pseudomallei; FLU-IG (NP025), a human polyclonal antibody therapeutic being developed to treat seasonal influenza; ZIKA-IG (NP024), a human polyclonal antibody therapeutic being developed as a prophylaxis for Zika infections; and FILOV (NP026), an equine polyclonal antibody therapeutic being developed to treat Ebola infections. In addition, the company provides contract manufacturing services to third-party customers. Emergent BioSolutions, Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Read More
How much money does Emergent Biosolutions Inc make?
News & Events about Emergent Biosolutions Inc.
PR Newswire
1 year ago
Thinking about buying stock in Eloxx Pharmaceuticals, Micron Technology, Emergent Biosolutions, Inflarx NV, or TG Therapeutics? Thinking about buying stock in Eloxx Pharmaceuticals, Micron Technology, Emergent Biosolutions, Inflarx NV, or TG Therapeutics? PR Newswire NEW YORK, April 10, 2023 NEW...
Globe Newswire
1 year ago
NARCAN Naloxone HCl Nasal Spray 4 mg is currently the first and only prescription strength naloxone nasal spray to receive over-the-counter status in the U.S., which is a critical step toward broadening accessExpected over-the-counter availability is anticipated by late summer of this year ...
Globe Newswire
1 year ago
Adds two revenue-generating vaccines for the prevention of cholera and typhoid fever that will establish Bavarian Nordic as a global leader in travel vaccinesBroadens development pipeline with a late-stage Chikungunya vaccine candidate with significant synergistic market opportunity in areas with a ...
Globe Newswire
1 year ago
GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that it has entered into an agreement to sell its travel health business to Bavarian Nordic (BVNRY) for a total value of up to $380 million, including potential future milestone payments. Under the...
PR Newswire
1 year ago
Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? PR Newswire NEW YORK, Jan. 6, 2023 NEW...
Frequently Asked Questions
Frequently Asked Questions
What is Emergent Biosolutions Inc share price today?
plus_minus_icon
Can Indians buy Emergent Biosolutions Inc shares?
plus_minus_icon
How can I buy Emergent Biosolutions Inc shares from India?
plus_minus_icon
Can Fractional shares of Emergent Biosolutions Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Emergent Biosolutions Inc stocks?
plus_minus_icon
What is today’s traded volume of Emergent Biosolutions Inc?
plus_minus_icon
What is today’s market capitalisation of Emergent Biosolutions Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Emergent Biosolutions Inc?
plus_minus_icon
What percentage is Emergent Biosolutions Inc down from its 52-Week High?
plus_minus_icon
What percentage is Emergent Biosolutions Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.55
$0.28
(5.31%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00